🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exercise Activity to Improve Mobility in Patients With CKD and PAD

RecruitingNAAges 18 Years - 80 YearsAllUniversity Hospital of Ferrara
NCT06621264 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

People affected by chronic kidney disease and concomitant diagnosed peripheral artery disease at intermediate stages, without contraindications to exercise therapy will be invited to participate in the study. Whose providing informed consent, will be randomly assigned to one of two groups: 1. Exercise program receiving two daily 10-minute interval walking sessions at a slow increasing speed. 2. Control group: receiving usual care including optimal medical therapy and nutritional advice. Patients of both groups will be measured at baseline, after the end of the exercise program (6-month) and at follow up (12-month). Outcome measures will include walking ability by the 6-minute walking test (primary outcome) and lower limbs perfusion, body composition, quality of life, laboratory outcomes and long-term hospitalizations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * chronic kidney disease at KDOQI stages III or IV and concomitant Peripheral artery disease at stages I, II, III; * ability to walk independently; * cognitive function to give informed consent identified by a Mini Mental Status Examination score greater or equal to 20/30 * absence of clinical conditions contraindicating exercise therapy (e.g., unstable angina, severe heart failure at NYHA class IV, anemia with lower than 10.0 g/dl). Exclusion Criteria: * major amputations; * major surgery planned in the next 3 months; * known comorbid conditions that may limit survival to less than 2 years; * inability or unwillingness to comply with protocol requirements.
💊

What it tests

  • EXERCISE TRAINING WITH OR WITHOUT MEDICATION
  • Control (Standard treatment)
📍

Where

3 sites
University Hospital of Ferrara
Ferrara, Italy
Ospedale Pederzoli Peschiera del Garda
Peschiera del Garda, Italy
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli
Reggio Calabria, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy